@article{602cd2e8456243ac8b165d0c816a43f9,
title = "Topiramate as an adjunct to amantadine in the treatment of dyskinesia in parkinson's disease: A randomized, double-blind, placebo-controlled multicenter study",
author = "Goetz, \{Christopher G.\} and Stebbins, \{Glenn T.\} and Chung, \{Kathryn A.\} and Nicholas, \{Anthony P.\} and Hauser, \{Robert A.\} and Douglas Merkitch and Stacy, \{Mark A.\}",
note = "Funding Information: Academy for Continued Healthcare Learning, Outcomes Insights, Expert Connect, HealthLogix, Cowen and Company, Pharma Two B, Ltd, Pfizer, Inc., and RMEI Medical Education for Better Outcomes. D.M. reports a salary from Rush University Medical Center. M.A.S. reports consulting and advisory board membership with honoraria from Acadia, Best Doctors, Biotie, Osmotica, Pfizer, Revance, Saraepta Therapeutics, and Sunovion Pharmaceuticals; grants and research from the Michael J. Fox Foundation, the National Institutes of Health, Parkinson Study Group, and Pharma2B; royalties from Informa Press for Handbook of Dystonia; and a salary from Duke University Medical Center. Funding Information: *Corresponding author: Dr. Christopher G. Goetz, Suite 755, Rush University Medical Center, 1725 W. Harrison Street, Chicago, IL 60612;
[email protected] Funding agency: This work was supported by a grant from the Michael J. Fox Foundation for Parkinson{\textquoteright}s Research.",
year = "2017",
month = sep,
day = "1",
doi = "10.1002/mds.27092",
language = "English (US)",
volume = "32",
pages = "1335--1336",
journal = "Movement Disorders",
issn = "0885-3185",
publisher = "John Wiley \& Sons Inc.",
number = "9",
}